Question 1

Does Los Angeles Capital Management own PTGX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Los Angeles Capital Management holds 4,727 shares of PTGX (Protagonist Therapeutics), worth $579,436.

Question 2

How many shares of PTGX does Los Angeles Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management holds 4,727 shares of PTGX (Protagonist Therapeutics).

Question 3

What is Los Angeles Capital Management's PTGX position worth?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management's PTGX position is worth $579,436.

Question 4

When did Los Angeles Capital Management first buy PTGX?

Accepted Answer

Los Angeles Capital Management first reported PTGX in its Q1 2020 13F and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	4,727	0.0%	$579,436	0.0%	$122.58	0
2026-Q1	Unchanged	4,727	0.0%	$498,226	0.0%	$105.40	0
2025-Q4	New	4,727	—	$367,999	0.0%	$87.34	33
2025-Q1	Exited	0	-100.0%	$0	0.0%	$48.36	0
2024-Q4	Increased	31,366	+39.7%	$1.2M	0.0%	$38.60	33
2024-Q3	Decreased	22,446	-27.2%	$1M	0.0%	$45.00	0